Cargando…
Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF-κB signaling pathway
Autores principales: | Ma, Hongzhong, Du, Juan, Feng, Xiaoli, Zhang, Yingjun, Wang, Haihuan, Ding, Suchun, Huang, Aijie, Ma, Jiahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283246/ https://www.ncbi.nlm.nih.gov/pubmed/34306185 http://dx.doi.org/10.3892/etm.2021.10343 |
Ejemplares similares
-
Rosiglitazone alleviates myocardial apoptosis in rats with acute myocardial infarction via inhibiting TLR4/NF-κB signaling pathway
por: Ma, Hongzhong, et al.
Publicado: (2020) -
IL-33 attenuates cardiac remodeling following myocardial infarction via inhibition of the p38 MAPK and NF-κB pathways
por: Yin, Honglei, et al.
Publicado: (2022) -
Retracted: Levosimendan Postconditioning Attenuates Cardiomyocyte Apoptosis after Myocardial Infarction
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2009) -
Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
por: Dormuth, Colin R., et al.
Publicado: (2010)